97 related articles for article (PubMed ID: 35141154)
1. A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec
Li Y; Fu Y; Cheng B; Xie X; Wang X
Front Oncol; 2021; 11():815213. PubMed ID: 35141154
[TBL] [Abstract][Full Text] [Related]
2. Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.
Gilbert L; Ratnam S; Jang D; Alaghehbandan R; Schell M; Needle R; Ecobichon-Morris A; Wadhawan A; Costescu D; Elit L; Wang P; Zahariadis G; Chernesky M
Cancer Biomark; 2022; 34(3):347-358. PubMed ID: 35001877
[TBL] [Abstract][Full Text] [Related]
3. CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings.
Ratnam S; Jang D; Gilbert L; Alaghehbandan R; Schell M; Needle R; Ecobichon-Morris A; Wang PP; Rahman M; Costescu D; Elit L; Zahariadis G; Chernesky M
Papillomavirus Res; 2020 Dec; 10():100206. PubMed ID: 32828968
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.
Sharma P; Gupta P; Gupta N; Suri V; Rajwanshi A
Turk Patoloji Derg; 2021; 37(1):32-38. PubMed ID: 33372263
[TBL] [Abstract][Full Text] [Related]
5. Validation of CINtec® PLUS Cytology Kit in the Diagnosis of Persistent HPV Infections - Cohort Study in the Portuguese Population.
Abreu ÂL; Silva RA; Fernandes S
J Cytol; 2021; 38(2):94-100. PubMed ID: 34321776
[TBL] [Abstract][Full Text] [Related]
6. p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.
Han Q; Guo H; Geng L; Wang Y
Chin J Cancer Res; 2020 Apr; 32(2):208-217. PubMed ID: 32410798
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review.
Tjalma WAA
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():275-280. PubMed ID: 28086168
[TBL] [Abstract][Full Text] [Related]
8. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
[TBL] [Abstract][Full Text] [Related]
9. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p16/Ki-67 Dual-Stained Cytology in Triaging HPV-Positive Women during Cervical Cancer Screening.
Hu Y; Hong Z; Gu L; Xie L; Yang B; Dai H; Chen H; Zhang B; Huang L; Liu Z; Cheng J; Zhang Y; Zhang Y; Lin J; Qiu L; Di W
Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1246-1252. PubMed ID: 32156721
[TBL] [Abstract][Full Text] [Related]
11. Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
Trzeszcz M; Mazurec M; Jach R; Mazurec K; Jach Z; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Prokopyk A; Barcikowski P; Przybylski M; Wach J; Halon A
Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829358
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions.
Pichon M; Joly M; Lebreton F; Benchaïb M; Mekki Y; Devouassoux-Shisheboran M
J Cytol; 2019; 36(3):152-156. PubMed ID: 31359914
[TBL] [Abstract][Full Text] [Related]
13. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
Gothwal M; Nalwa A; Singh P; Yadav G; Bhati M; Samriya N
J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802
[TBL] [Abstract][Full Text] [Related]
14. A cocktail of p16
Wang HR; Li YC; Guo HQ; Yu LL; Wu Z; Yin J; Liao GD; Qu YM; Jiang Y; Wang D; Chen W
Oncotarget; 2017 Oct; 8(48):83890-83899. PubMed ID: 29137390
[TBL] [Abstract][Full Text] [Related]
15. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results.
Reuschenbach M; Clad A; von Knebel Doeberitz C; Wentzensen N; Rahmsdorf J; Schaffrath F; Griesser H; Freudenberg N; von Knebel Doeberitz M
Gynecol Oncol; 2010 Oct; 119(1):98-105. PubMed ID: 20619445
[TBL] [Abstract][Full Text] [Related]
16. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
[TBL] [Abstract][Full Text] [Related]
17. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
18. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
[TBL] [Abstract][Full Text] [Related]
19. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
